Sprint Bioscience AB (publ) SPRINT.ST Stock
1.28 SEK
{{ price }}
5.445543%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
89.23M SEK
LOW - HIGH [24H]
1.23
-
1.29 SEK
VOLUME [24H]
57.19K SEK
{{ volume }}
P/E Ratio
9.83
Earnings per share
0.13 SEK
Sprint Bioscience AB (publ) Price Chart
Sprint Bioscience AB (publ) SPRINT.ST Financial and Trading Overview
| Sprint Bioscience AB (publ) stock price | 1.28 SEK |
| Previous Close | 0.55 SEK |
| Open | 0.51 SEK |
| Bid | 0.51 SEK x 0 |
| Ask | 0.53 SEK x 0 |
| Day's Range | 0.47 - 0.55 SEK |
| 52 Week Range | 0.45 - 3.38 SEK |
| Volume | 153.14K SEK |
| Avg. Volume | 229.24K SEK |
| Market Cap | 36.75M SEK |
| Beta (5Y Monthly) | 1.354789 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.13 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.6 SEK |
SPRINT.ST Valuation Measures
| Enterprise Value | 11.14M SEK |
| Trailing P/E | N/A |
| Forward P/E | 2.54 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 35.33199 |
| Price/Book (mrq) | 2.2280703 |
| Enterprise Value/Revenue | 10.716 |
| Enterprise Value/EBITDA | -0.192 |
Trading Information
Sprint Bioscience AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.354789 |
| 52-Week Change | -82.83% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.38 SEK |
| 52 Week Low | 0.45 SEK |
| 50-Day Moving Average | 0.65 SEK |
| 200-Day Moving Average | 0.86 SEK |
SPRINT.ST Share Statistics
| Avg. Volume (3 month) | 229.24K SEK |
| Avg. Daily Volume (10-Days) | 257.17K SEK |
| Shares Outstanding | 69.8M |
| Float | 53.6M |
| Short Ratio | N/A |
| % Held by Insiders | 35.31% |
| % Held by Institutions | 2.58% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -5628.17% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -74.62% |
| Return on Equity (ttm) | -161.46% |
Income Statement
| Revenue (ttm) | 1.04M SEK |
| Revenue Per Share (ttm) | 0.02 SEK |
| Quarterly Revenue Growth (yoy) | 1805.69% |
| Gross Profit (ttm) | -12847000 SEK |
| EBITDA | -57928000 SEK |
| Net Income Avi to Common (ttm) | -58249000 SEK |
| Diluted EPS (ttm) | -1.24 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 27.24M SEK |
| Total Cash Per Share (mrq) | 0.39 SEK |
| Total Debt (mrq) | 0 SEK |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.742 |
| Book Value Per Share (mrq) | 0.228 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -47641000 SEK |
| Levered Free Cash Flow (ttm) | -26120000 SEK |
Profile of Sprint Bioscience AB (publ)
| Country | Sweden |
| State | N/A |
| City | Huddinge |
| Address | Novum |
| ZIP | 141 57 |
| Phone | 46 84 11 44 55 |
| Website | https://www.sprintbioscience.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 29 |
Sprint Bioscience AB (publ) develops pharmaceutical products in the areas of cancer and metabolism in Sweden, Europe, the United States, and Asia. It engages in developing VPS34, a drug candidate for the treatment of various types of cancer; and PETRA01, a drug candidate for the treatment of cancer. The company also focuses on research of products for the treatment of tumor metabolism and type 2 diabetes. Sprint Bioscience AB (publ) was founded in 2009 and is based in Huddinge, Sweden.
Q&A For Sprint Bioscience AB (publ) Stock
What is a current SPRINT.ST stock price?
Sprint Bioscience AB (publ) SPRINT.ST stock price today per share is 1.28 SEK.
How to purchase Sprint Bioscience AB (publ) stock?
You can buy SPRINT.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sprint Bioscience AB (publ)?
The stock symbol or ticker of Sprint Bioscience AB (publ) is SPRINT.ST.
Which industry does the Sprint Bioscience AB (publ) company belong to?
The Sprint Bioscience AB (publ) industry is Biotechnology.
How many shares does Sprint Bioscience AB (publ) have in circulation?
The max supply of Sprint Bioscience AB (publ) shares is 69.82M.
What is Sprint Bioscience AB (publ) Price to Earnings Ratio (PE Ratio)?
Sprint Bioscience AB (publ) PE Ratio is 9.83077000 now.
What was Sprint Bioscience AB (publ) earnings per share over the trailing 12 months (TTM)?
Sprint Bioscience AB (publ) EPS is 0.13 SEK over the trailing 12 months.
Which sector does the Sprint Bioscience AB (publ) company belong to?
The Sprint Bioscience AB (publ) sector is Healthcare.
Sprint Bioscience AB (publ) SPRINT.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| First North Sweden SEK PI FNSESEKPI | 1878.6 SEK 183.37 USD |
+0.16
|
— — | 1870.08 SEK 182.54 USD | 1889.76 SEK 184.46 USD | — - | — — |
| First North Sweden EUR PI FNSEEURPI | 1513.01 EUR 1653.92 USD |
+0.67
|
— — | 1510.95 EUR 1651.67 USD | 1533.41 EUR 1676.23 USD | — - | — — |
| First North Health Care PI FN20PI | 934.74 EUR 1021.8 USD |
-1.95
|
— — | 933.5 EUR 1020.44 USD | 953.35 EUR 1042.15 USD | — - | — — |
| First North All-Share SEK FIRSTNORTHSEK | 126.34 SEK 12.33 USD |
-0.9
|
— — | 126.23 SEK 12.32 USD | 127.53 SEK 12.45 USD | — - | — — |
| First North All-Share DKK FIRSTNORTHDKK | 101.04 DKK 14.82 USD |
-1.33
|
— — | 100.96 DKK 14.8 USD | 102.42 DKK 15.02 USD | — - | — — |
| First North Sweden SEK GI FNSESEKGI | 2001.34 SEK 195.36 USD |
-1.07
|
— — | 1999.37 SEK 195.16 USD | 2020.41 SEK 197.22 USD | — - | — — |
| First North Sweden EUR GI FNSEEURGI | 1616.97 EUR 1767.57 USD |
-1.5
|
— — | 1615.38 EUR 1765.82 USD | 1639.39 EUR 1792.08 USD | — - | — — |
| First North Health Care GI FN20GI | 939.04 EUR 1026.5 USD |
-1.95
|
— — | 937.79 EUR 1025.13 USD | 957.74 EUR 1046.94 USD | — - | — — |
| First North All-Share EUR FIRSTNORTHEUR | 100.98 EUR 110.38 USD |
-1.33
|
— — | 100.89 EUR 110.29 USD | 102.35 EUR 111.88 USD | — - | — — |
- {{ link.label }} {{link}}